SLC2A1 and amyotrophic lateral sclerosis: Regardless, given that Glut1 function was increased at the BBB in C9 mice, as assessed by increased BBB trafficking of 3H-2DG, this transporter is still considered an exploitable target for improving CNS drug delivery in ALS.